Collaborative Research

As the sponsor of the study, the investigator and/or institution assume responsibility for all aspects of the study.

• Institutional and regulatory approvals and reporting
  • IRB/EC approval
  • Registration on ClinicalTrials.gov
  • Serious adverse event reporting to Smith+Nephew and locally - according to Regulatory requirements in your country
• Study conduct in accordance with ICH GCP Guidelines and all applicable local and regulatory requirements
• Communication of all ongoing study updates (see section below)

The Investigator needs to complete a study proposal and budget, these will be provided once you have selected the relevant study type below.

If the full proposal is approved, a contract will be sent for execution between the investigator, and Smith+Nephew. Support is contingent upon a fully executed contract, compliance with the terms and conditions of the contract, and submission of the following required documentation:

• IRB/EC Approval Letter and Final IRB Approved Protocol
• IND/IDE Application Submission to FDA, if applicable
• Registration on ClinicalTrials.gov, if applicable
• Institutional Sub-W9

We will consider reasonable requests for funding in support of an IIS. All full proposal submissions must include an itemized budget with costs a template will be available within the submission form if needed. Requestors may use their own template or the Smith+Nephew template that is provided here. Line item allocations should be specified for each aspect of the study, such as study start-up fees (e.g., IRB submission), study visits (e.g., physical exam, vital signs, pregnancy test), and publication costs (e.g., medical writer).

Researchers are invited to submit their concept proposal using the ‘Submit Proposal’ button. Each submission will be reviewed collectively by the Smith+Nephew Review Committee based on scientific merit and alignment with corporate research, key business objectives and development plans.